Indication
Heavy menstrual bleeding
9 clinical trials
19 products
Clinical trial
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenStatus: Active (not recruiting), Estimated PCD: 2024-07-11
Product
ElagolixProduct
E2/NETAClinical trial
LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsStatus: Completed, Estimated PCD: 2020-01-21
Product
RelugolixProduct
Estradiol + NorethindroneProduct
BG2109Clinical trial
A Phase 3, Multicentre, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Daily Oral Administration of BG2109 Alone and in Combination With Add-back Therapy for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women.Status: Recruiting, Estimated PCD: 2024-05-01
Product
PlaceboProduct
Add-back therapyClinical trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareStatus: Completed, Estimated PCD: 2019-11-01
Product
POPSClinical trial
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine BleedingStatus: Recruiting, Estimated PCD: 2025-01-01
Product
FerumoxytolProduct
Ferrous SulfateClinical trial
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders StudyStatus: Not yet recruiting, Estimated PCD: 2028-12-01
Product
NorethindroneClinical trial
Alternate Day Versus Daily Oral Iron Therapy in Adolescents With Iron Deficiency Anemia and Heavy Menstrual Bleeding: A Feasibility TrialStatus: Completed, Estimated PCD: 2022-06-30
Product
Ferrous sulfateClinical trial
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot StudyStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Product
Tranexamic acidClinical trial
Prospective, Observational, Non-interventional Open-label Multicenter Registry Regarding the Incidence of Heavy Menstrual Bleeding in Women of Reproductive Age Treated With Direct Oral Anticoagulants Because of Venous ThromboembolismStatus: Active (not recruiting), Estimated PCD: 2024-05-31
Product
ApixabanProduct
RivaroxabanProduct
EdoxabanProduct
Dabigatran